Literature DB >> 30295241

[Effect of FBXW7 and NOTCH1 Mutations on Prognosis of Patients with Adult Acute T Lymphoblastic Leukemia].

Hui Liu1, Ling Zhu1, Yu-Hong Liu2.   

Abstract

OBJECTIVE: To investigate the mutation rate and mutation characteristics of FBXW7 and NOTCH1 in adult T-ALL, and to study the effect of these 2 mutations on the clinical features and prognosis of patients with adult T-ALL.
METHODS: The mutations of FBXW7 and NOTCH1 in 106 adult T-ALL patients were determined by gene sequencing of FBXW7 and NOTCH1 genes. and the clinical characteristics and prognosis were compared.
RESULTS: Among the 106 cases of adult T-ALL, there were 21 cases (19.8%) of FBXW7 mutation, 66 cases (62.3%) of NOTCH1 mutation and 18 cases (17.0%) of FBXW7 / NOTCH1 double mutations. The 2-year cumulative overall survival rate and event-free survival rate of the patiants in FBXW7 / NOTCH1 double mutant group were lower than those without mutations (27.8% vs 70.3%)(P<0.01) and (16.7% vs 48.6%) ( P<0.01) respectivly, but the FBXW7 or NOTCH1 mutations had a little effect on the prognosis. The recurrence rate at mutant group was higher than that of the non - mutant group (77.8% vs 43.2%) (P<0.05).
CONCLUSION: FBXW7 or NOTCH1 mutations can not be as the prognostic factors, but the FBXW7 / NOTCH1 double mutations may indicate poor prognosis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30295241     DOI: 10.7534/j.issn.1009-2137.2018.05.007

Source DB:  PubMed          Journal:  Zhongguo Shi Yan Xue Ye Xue Za Zhi        ISSN: 1009-2137


  2 in total

1.  [Prognostic analysis of patients with mutations in the JAK/STAT signaling pathway in adult acute lymphoblastic leukemia].

Authors:  W J Fan; T T Xu; J J Guo; Y F Li; Z X Jiang
Journal:  Zhonghua Xue Ye Xue Za Zhi       Date:  2021-07-14

Review 2.  Fate of hematopoietic stem cells determined by Notch1 signaling (Review).

Authors:  Yidong Ge; Jie Wang; Hui Zhang; Jinyun Li; Meng Ye; Xiaofeng Jin
Journal:  Exp Ther Med       Date:  2021-12-27       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.